Alimera Sciences, Inc. (NASDAQ:ALIM – Get Free Report) was the recipient of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 103,900 shares, a decline of 14.6% from the April 30th total of 121,700 shares. Based on an average daily trading volume, of 67,700 […]
AIGH Capital Management LLC lowered its stake in shares of Alimera Sciences, Inc. (NASDAQ:ALIM – Free Report) by 6.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,226,068 shares of the biopharmaceutical company’s stock after selling 146,504 […]
StockNews.com initiated coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research report sent to investors on Wednesday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and set a $5.00 target price on shares of Alimera Sciences in a research report on […]
StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a research report report published on Sunday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. ALIM has been the subject of a number of other reports. Craig Hallum cut their price objective on shares of Alimera Sciences from […]
StockNews.com assumed coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a research report released on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. Other equities analysts also recently issued reports about the company. Craig Hallum dropped their target price on Alimera Sciences from $18.00 to $8.00 in a […]